Log in to save to my catalogue

Ticagrelor in Patients with Stable Coronary Disease and Diabetes

Ticagrelor in Patients with Stable Coronary Disease and Diabetes

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_395718

Ticagrelor in Patients with Stable Coronary Disease and Diabetes

About this item

Full title

Ticagrelor in Patients with Stable Coronary Disease and Diabetes

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2019-10, Vol.381 (14), p.1309-1320

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

Patients with stable coronary artery disease and diabetes were randomly assigned to receive either ticagrelor plus aspirin or placebo plus aspirin. At 40 months, the incidence of the composite efficacy outcome of cardiovascular death, myocardial infarction, or stroke was lower with ticagrelor than with placebo; the frequency of major bleeding was h...

Alternative Titles

Full title

Ticagrelor in Patients with Stable Coronary Disease and Diabetes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_DiVA_org_uu_395718

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_395718

Other Identifiers

ISSN

0028-4793,1533-4406

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1908077